If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Mauro Zaccarelli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 62 Similar Profiles
HIV Medicine & Life Sciences
HIV-1 Medicine & Life Sciences
efavirenz Medicine & Life Sciences
Highly Active Antiretroviral Therapy Medicine & Life Sciences
Tenofovir Medicine & Life Sciences
Ritonavir Medicine & Life Sciences
CD4 Lymphocyte Count Medicine & Life Sciences
Reverse Transcriptase Inhibitors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2019

  • 3064 Citations
  • 30 h-Index
  • 182 Article
  • 2 Letter

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

ICONA Foundation Study group, Oct 15 2019, In : BMC Public Health. 19, 1, p. 1-13 13 p., 1291.

Research output: Contribution to journalArticle

Open Access
Coinfection
Alcohol Drinking
Liver Diseases
HIV
Physicians

Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients

Ungaro, R., Taramasso, L., Bruzzone, B., Vicenti, I., Galli, L., Borghi, V., Francisci, D., Pecorari, M., Zoncada, A., Callegaro, A. P., Paolini, E., Monno, L., Bonora, S., Di Biagio, A., Giacometti, A., Butini, L., del Gobbo, R., Bagnarelli, P., Tacconi, D., Corbelli, G. & 30 others, Zanussi, S., Monno, L., Punzi, G., Maggiolo, F., Calza, L., Carla Re, M., Pristera, R., Turconi, P., Mandas, A., Tini, S., Zoncada, A., Paolini, E., Amadio, G., Sighinolfi, L., Corsi, P., Galli, L., Di Pietro, M., Colao, G., Biondi, M. L., Maserati, R., Filice, G., Baldanti, F., Magnani, G., Palmisano, L., Antinori, A., Zaccarelli, M., De Luca, A., Rossi, C., Grossi, P. & Seminari, E., Nov 1 2019, In : Clinical Microbiology and Infection. 25, 11, p. 1443-1446 4 p.

Research output: Contribution to journalLetter

2 Citations (Scopus)
efavirenz
etravirine
Rilpivirine
Reverse Transcriptase Inhibitors
HIV-1

Randomized clinical trial on efficacy of fixed-dose efavirenz/tenofovir/emtricitabine on alternate days versus continuous treatment

ATAD Study Group, Bellagamba, R., Giancola, M. L., Tommasi, C., Piselli, P., Tempestilli, M., Angeletti, C., Zaccarelli, M., Ammassari, A., Pinnetti, C., Gallo, A. L., Antinori, A., Narciso, P. & Nicastri, E., Mar 1 2019, In : AIDS (London, England). 33, 3, p. 493-502 10 p.

Research output: Contribution to journalArticle

Tenofovir
efavirenz
Randomized Controlled Trials
Therapeutics
CD4 Lymphocyte Count
Street Drugs
Sexually Transmitted Diseases
Italy
HIV
Cocaine